Drug-Levels
Showing 9976 - 10000 of >10,000
Hypoglycemia, Roux-en-Y Gastric Bypass, Post-bariatric Hypoglycemia Trial in Boston (Physical activity (cycling on a stationary
Recruiting
- Hypoglycemia
- +3 more
- Physical activity (cycling on a stationary bicycle ergometer)
-
Boston, MassachusettsJoslin Diabetes Center
Nov 16, 2022
Adult Angiosarcoma, Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma Trial in United States
Completed
- Adult Angiosarcoma
- +3 more
-
Santa Monica, California
- +6 more
Mar 29, 2022
Metastatic Breast Cancer, Recurrent Breast Cancer Trial in Boston, Nashville (Taselisib, Trastuzumab emtansine, Pertuzumab)
Active, not recruiting
- Metastatic Breast Cancer
- Recurrent Breast Cancer
- Taselisib
- +4 more
-
Boston, Massachusetts
- +2 more
Mar 21, 2022
HEPATITIS C, Virus, Human Immunodeficiency Trial in Aurora (Directly Observed Therapy, Wirelessly Observed Therapy)
Completed
- HEPATITIS C
- Virus, Human Immunodeficiency
- Directly Observed Therapy
- Wirelessly Observed Therapy
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Mar 4, 2022
Analysis of Gingival Crevicular Fluid
Completed
- Periodontal Diseases
- Gingival crevicular fluid sampling
- (no location specified)
Apr 6, 2022
Postprandial Triglyceride and Glucose Responses
Completed
- Lipid Metabolism
- Glucose Metabolism
- Mixed meal challenge test
- +4 more
-
Wageningen, Gelderland, NetherlandsStichting Wageningen Research
Jul 4, 2022
Tooth Extraction Trial in London (Remimazolam, Midazolam)
Recruiting
- Tooth Extraction
-
London, United KingdomGuy's and St Thomas' NHS Foundation Trust
Mar 17, 2022
Heart Failure With Preserved Ejection Fraction Trial in Minneapolis (Cilostazol 100Mg Tab, Placebo)
Completed
- Heart Failure With Preserved Ejection Fraction
- Cilostazol 100Mg Tab
- Placebo
-
Minneapolis, MinnesotaM Health Fairview
Jul 12, 2022
Breast Cancer, Triple Negative Breast Tumors Trial in France (Nivolumab, Ipilimumab, Capecitabine)
Active, not recruiting
- Breast Cancer
- Triple Negative Breast Neoplasms
- Nivolumab
- +2 more
-
Angers, France
- +16 more
Jul 21, 2022
Covid19 Trial (Aerosolized 13 cis retinoic acid plus Inhalation Inhaled testosterone, The standard therapy)
Unknown status
- Covid19
- Aerosolized 13 cis retinoic acid plus Inhalation Inhaled testosterone
- The standard therapy
- (no location specified)
Nov 9, 2020
COPD (COPD) Trial in Lincoln (TD-4208)
Completed
- Chronic Obstructive Pulmonary Disease (COPD)
-
Lincoln, NebraskaCelerion
Feb 22, 2022
PRediction of Acute Coronary Syndrome in Acute Ischemic StrokE
Active, not recruiting
- Stroke, Ischemic
- Acute Coronary Syndrome
- Coronary angiography
-
Bad Neustadt An Der Saale, Germany
- +27 more
Mar 9, 2022
Predominant Sensitizations to Single Bee Venom Allergens asRisk
Recruiting
- Bee Venom Allergy
- Insect Venom
-
Graz, AustriaDepartment of Dermatology and Venerology, Medical University of
Apr 5, 2022
End Stage Renal Disease, Restless Legs Syndrome Trial in Halifax, Hamilton, Ottawa (Gabapentin, Ropinirole, Placebo Gabapentin)
Completed
- End Stage Renal Disease
- Restless Legs Syndrome
- Gabapentin
- +3 more
-
Halifax, Nova Scotia, Canada
- +2 more
Sep 19, 2022
T Cell Lymphoma Trial in Seoul (ACHOP)
Not yet recruiting
- T Cell Lymphoma
-
Seoul, Korea, Republic of81, Irwon-ro, Gangnam-gu, Seoul, Republic of Korea
Apr 18, 2022
Effectiveness and Cost-effectiveness of LADB
Not yet recruiting
- Opioid Dependence
- long-acting depot buprenorphine (LADB)
- (no location specified)
Nov 16, 2023
Stress, Depression, Anxiety Trial in Seattle (Amigas Latinas Motivando el Alma (ALMA))
Completed
- Stress
- +2 more
- Amigas Latinas Motivando el Alma (ALMA)
-
Seattle, Washington
- +1 more
Apr 29, 2022
Depression, Serotonin Deficiency Trial in Kelowna (Pharmacological agent: Citalopram, Placebo)
Not yet recruiting
- Depression
- Serotonin Deficiency
- Pharmacological agent: Citalopram
- Placebo
-
Kelowna, British Columbia, CanadaUniversity of British Columbia, Okanagan Campus
Jul 19, 2023
Opioid Use Disorder Trial (Mom Power)
Not yet recruiting
- Opioid Use Disorder
- Mom Power
- (no location specified)
Nov 11, 2022
Rheumatoid Arthritis Trial in Shibin Al Kawm (Placebo, Ursodeoxycholic acid (UDCA) 500 mg)
Recruiting
- Rheumatoid Arthritis
- Placebo
- Ursodeoxycholic acid (UDCA) 500 mg
-
Shibīn Al Kawm, EgyptMenoufia University Hospital
Aug 1, 2023
Lymphoma, Solid Tumor Trial in Buffalo (Gemcitabine Hydrochloride, Laboratory Biomarker Analysis, Pharmacological Study)
Terminated
- Lymphoma
- Solid Neoplasm
- Gemcitabine Hydrochloride
- +3 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Healthy Non-dependent, Recreational Sedative Users, Abuse Potential Trial in Overland Park, Montreal (Suvorexant, Zolpidem,
Recruiting
- Healthy Non-dependent, Recreational Sedative Users
- Abuse Potential
- Suvorexant
- +3 more
-
Overland Park, Kansas
- +1 more
Jan 31, 2023